We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Mecasermin, when administered at the highest end of the ...
Discover comprehensive details about Mecasermin [rDNA origin] Injection, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The ...
Review the side-effects of Mecasermin [rDNA origin] Injection as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the ...
Please provide your email address to receive an email when new articles are posted on . Patients treated with mecasermin for use in pediatric growth failure had significant height increases and ...
DEER PARK, Ill., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing ...
A Phase 1 clinical trial using mecasermin [recombinant human insulin-like growth factor 1 (IGF-1)] has been completed for Rett Syndrome research, showing proof-of-principle that treatments like IGF-1 ...
Product is now available through AnovoRx, a specialty pharmacy dedicated to serving patients with rare and chronic conditions DEER PARK, Ill., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, ...
it has avoided an interruption in US supply of Increlex® (IGF-1) for the treatment of Severe Primary IGF-1 Deficiency due to delays in manufacturing site approval. Increlex® is an important drug used ...
(Cincinnati, OH) – The results from Boston Children's Hospital's Phase 1 human clinical trial in Rett syndrome came out today. A team of investigators successfully completed a Phase 1 clinical trial ...
Aligns with Eton's Mission to Develop and Distribute Medicines that Have a Life Changing Impact for Patients with Ultra-rare Conditions Acquisition to Bolster Eton’s Commercial Pediatric Endocrinology ...
Acquisition bolsters Eton's commercial pediatric endocrinology portfolio Product is now available through AnovoRx, a specialty pharmacy dedicated to serving patients with rare and chronic conditions ...